Inventor · disambiguated record
Stephen Paul Collingwood
Also filed as: COLLINGWOOD STEPHEN · COLLINGWOOD STEPHEN P · COLLINGWOOD STEPHEN PAUL
36 granted patents·21 pending applications·1,885 citations·filing 1994–2023
97Inventor score
Top patents by PatentIndex Score
57 records- 0198US5466677ADinucleoside phosphinates and their pharmaceutical compositionsCIBA GEIGY CORP·Filed 1994·Granted Nov 14, 1995·1.2k cites·11 claims
- 0294US6589950B1Purine derivatives inhibitors of tyrosine protein kinase SYKNOVARTIS AG·Filed 2000·Granted Jul 8, 2003·106 cites·12 claims
- 0392US5508270ANucleoside phosphinate compounds and compositionsCIBA GEIGY CORP·Filed 1994·Granted Apr 16, 1996·391 cites·10 claims
- 0489US8236808B2Pyrazine derivatives as ENAC blockersCOLLINGWOOD STEPHEN PAUL·Filed 2009·Granted Aug 7, 2012·21 cites·8 claims
- 0587US11208381B2Indole derivatives and their use as protein kinase inhibitorsRESPIVERT LTD·Filed 2020·Granted Dec 28, 2021·2 cites·18 claims
- 0687US8153669B2Quaternary ammonium salts as M3 antagonistsPRESS NEIL JOHN·Filed 2005·Granted Apr 10, 2012·16 cites·8 claims
- 0787US8039472B2Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channelNOVARTIS AG·Filed 2008·Granted Oct 18, 2011·8 cites·19 claims
- 0883US10669235B2Indole derivatives and their use as protein kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Jun 2, 2020·2 cites·13 claims
- 0983US8664228B23,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseasesCOLLINGWOOD STEPHEN PAUL·Filed 2009·Granted Mar 4, 2014·7 cites·3 claims
- 1083US7803804B2Substituted pyrazines for use in the treatment of inflammatory or allergic conditionsNOVARTIS AG·Filed 2006·Granted Sep 28, 2010·6 cites·3 claims
- 1180US11364246B2CompoundsTMEM16A LTD·Filed 2019·Granted Jun 21, 2022·2 cites·11 claims
- 1278US7723356B2Quinuclidine derivatives and their use as muscarinic m3 receptor antagonistsNOVARTIS AG·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 1376US9139586B2Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesBHALAY GURDIP·Filed 2014·Granted Sep 22, 2015·2 cites·7 claims
- 1476US2021236478A1Combinations of Glycopyrrolate and Beta2 Adrenoceptor AgonistsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1575US8318935B2Organic compounds 75074FAIRHURST ROBIN ALEC·Filed 2008·Granted Nov 27, 2012·3 cites·19 claims
- 1674US8697687B2Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesBHALAY GURDIP·Filed 2012·Granted Apr 15, 2014·2 cites·3 claims
- 1774US7947730B2Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptorNOVARTIS AG·Filed 2004·Granted May 24, 2011·7 cites·9 claims
- 1873US6919337B28-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsNOVARTIS AG·Filed 2003·Granted Jul 19, 2005·9 cites·15 claims
- 1970US8168654B2Quinuclidine derivatives binding to mucarinic M3 receptorsCOLLINGWOOD STEPHEN P·Filed 2009·Granted May 1, 2012·2 cites·16 claims
- 2068US2019282561A1Combinations of Glycopyrrolate and Beta2 Adrenoceptor AgonistsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2167US2013237564A1Combinations of Glycopyrrolate and Beta2 Adrenoceptor AgonistsCOLLINGWOOD STEPHEN PAUL·Filed 2013·Application pending·0 cites
- 2265US6562960B1Oligonucleotide analoguesISIS PHARMACEUTICALS INC·Filed 1997·Granted May 13, 2003·20 cites·45 claims
- 2364US2018071276A1Combinations of Glycopyrrolate and Beta2 Adrenoceptor AgonistsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2464US2016101097A1Combinations of Glycopyrrolate and Beta2 Adrenoceptor AgonistsCOLLINGWOOD STEPHEN PAUL·Filed 2015·Application pending·0 cites
- 2563US6087490ADinucleotide and oligonucleotide analoguesNOVARTIS AG·Filed 1997·Granted Jul 11, 2000·16 cites·18 claims
- 2662US2006173181A18-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsBHALAY GURDIP·Filed 2005·Application pending·0 cites
- 2761US12377105B2CompoundsTMEM16A LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 2859US7361661B28-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsBHALAY GURDIP·Filed 2006·Granted Apr 22, 2008·0 cites·3 claims
- 2959US2024132467A1Benzimidazole derivatives for treating respiratory diseaseTMEM16A LTD·Filed 2023·Application pending·0 cites
- 3058US5952478AIntermediates for dinucleotide and oligonucleotide analoguesNOVARTIS FINANCE CORP·Filed 1995·Granted Sep 14, 1999·12 cites·24 claims
- 3157US2008267886A1Combinations of Glycopyrrolate and Beta2 Adrenoceptor AgonistsCOLLINGWOOD STEPHEN PAUL·Filed 2005·Application pending·0 cites
- 3256US9073921B2Salt forms of bicyclic heterocyclic derivativesBRUCE IAN·Filed 2014·Granted Jul 7, 2015·0 cites·17 claims
- 3356US5670489AOligonucleotide analoguesNOVARTIS AG·Filed 1995·Granted Sep 23, 1997·12 cites·14 claims
- 3455US7019136B28-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsNOVARTIS AG·Filed 2004·Granted Mar 28, 2006·0 cites·1 claims
- 3555US2011237572A1Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesNOVARTIS AG·Filed 2011·Application pending·0 cites
- 3653US12415793B2Modulators of TMEM16A for treating respiratory diseaseTMEM16A LTD·Filed 2021·Granted Sep 16, 2025·0 cites·13 claims
- 3753US9643983B2Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesBHALAY GURDIP·Filed 2015·Granted May 9, 2017·0 cites·6 claims
- 3851US9751876B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionNOVARTIS AG·Filed 2014·Granted Sep 5, 2017·0 cites·18 claims
- 3949US12162836B2N-acyl-{4-[(4-aryl-phenyl)sulfonylmethyl]piperidine} compounds and their therapeutic useMODERN BIOSCIENCES LTD·Filed 2020·Granted Dec 10, 2024·0 cites·25 claims
- 4049US2022235006A1Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditionsTMEM16A LTD·Filed 2022·Application pending·0 cites
- 4147US12281077B2Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamideTMEM16A LTD·Filed 2022·Granted Apr 22, 2025·0 cites·18 claims
- 4246US2008279948A1Treatment of Asthma and Copd Using Triple-Combination TherapyNXP BV·Filed 2006·Application pending·0 cites
- 4346US2008312212A1Organic CompoundsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 4445US8883819B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionBRUCE IAN·Filed 2012·Granted Nov 11, 2014·0 cites·20 claims
- 4545US2009264459A1Organic CompoundsCOLLINGWOOD STEPHEN PAUL·Filed 2007·Application pending·0 cites
- 4645US2007060563A1Quinuclidine derivatives binding to mucarinic m3 receptorsCOLLINGWOOD STEPHEN P·Filed 2004·Application pending·0 cites
- 4744US2008317862A1Organic Compounds Comprising a Glycopyrrolium SaltCOLLINGWOOD STEPHEN PAUL·Filed 2006·Application pending·0 cites
- 4844US2008286363A1Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways DiseasesCOLLINGWOOD STEPHEN PAUL·Filed 2006·Application pending·0 cites
- 4944US2008274189A1Organic Compounds Comprising a Glycopyrr Onium SaltCOLLINGWOOD STEPHEN PAUL·Filed 2006·Application pending·0 cites
- 5043US2020361871A1CompoundsENTPR THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen Paul Collingwood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →